How is the mutational status for tumor suppressors p53 and p16(INK4A) in MFH of the bone?
Both tumor suppressor genes p53 and p16(INK4A) play a crucial role in the control of cell cycle and tumor development. In this study 19 malignant fibrous histiocytomas of the bone (MFH-b), a very rare sarcoma entity, were investigated for mutations in p53 and p16 genes by a PCR-SSCP-sequencing analysis. In the tumor samples two p53 mutations and two polymorphisms (one in the p53 gene and one in the p16 gene) were found. The occurrence rate for p53 mutations and the absence of p16 mutations in MFH-b are comparable to the findings for MFH of soft tissues (MFH-st) and osteosarcomas, suggesting that p53 rather than p16 may play a role in tumorigenesis of MFH-b.
Taubert
H
H
Institute of Pathology, Martin Luther University of Halle-Wittenberg, Halle/Saale, Germany. helge_taubert@medizin.uni-halle.de
Berger
D
D
Hinze
R
R
Meye
A
A
Würl
P
P
Hogendoorn
P C
PC
Holzhausen
H J
HJ
Schmidt
H
H
Rath
F W
FW
D001859:Bone Neoplasms / Q000235:genetics*; D004273:DNA, Neoplasm / Q000032:analysis; D019942:Genes, p16 / Q000235:genetics*; D016158:Genes, p53 / Q000235:genetics*; D018219:Histiocytoma, Benign Fibrous / Q000235:genetics*; D006801:Humans; D009154:Mutation; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D018807:Polymorphism, Single-Stranded Conformational
D004273:DNA, Neoplasm